The Program Committee is pleased to announce the three keynote sessions to be delivered at the 2013 Annual Meeting, April 21-24 in Colorado Springs, Colorado.

Shawn Shea, MD, is the lead-off keynote speaker for the 2013 Annual Meeting offering a session entitled The Medication Interest Model (MIM): Innovative Interviewing Techniques for Improving Medication Adherence. Dr. Shea is the Director of the Training Institute for Suicide Assessment and Clinical Interviewing, a training and consultation service providing workshops, consultations, and quality assurance design in mental health assessments. Dr. Shea also maintains a private practice.

As evidenced by this edition of the Mental Health Clinician, one of the greatest challenges for pharmacists, as they try to help patients coping with disorders such as major depression, bipolar disorder, and schizophrenia is improving medication adherence. In this keynote Dr. Shea looks directly, with a no-nonsense practicality, at the methods by which clinicians address this crucial topic as they build their alliances with their patients.

An internationally acclaimed workshop leader and educational innovator in the fields of suicide prevention, resiliency, clinical interviewing, and improving medication adherence, Dr. Shea brings to life the practical interviewing techniques of the Medication Interest Model (MIM). The MIM explores how a clinician's language is often the determining factor in whether or not the clinician is viewed as an opponent “pushing meds” or as an ally helping to provide useful information on both the benefits and side-effects of medications. Specific interviewing techniques, choices of word, and strategies are described in detail in a fast-paced, lively and compelling style. Referring to Dr. Shea's book, “Improving Medication Adherence: How to Talk with Patients About Their Medication” from which the presentation is based, Former Surgeon General C. Everett Koop comments: “With sophistication, wit, astute clinical observation, and a vibrant sense of compassion Shea throws a brilliant new light on one of the most crucial topics in medicine - improving medication adherence.”

Newer synthetic drugs of abuse are extremely commonly used, especially among youths. They are readily available at gas stations, head shops, or online; there is no age restriction for buying them; and youths assume they are not dangerous because they can be legally purchased. Despite their widespread use, many health care workers are relatively unfamiliar with newer synthetic drugs of abuse. These drugs have clinical consequences, some of which can be life-threatening, and they are responsible for ever-increasing numbers of emergency department visits and calls to poison control centers. The legal landscape surrounding these drugs has been changing. Furthermore, drug testing to detect these substances has had to evolve.

Dr. H. Westley Clark, MD, JD, MPH, CAS, FASAM, Director, Center for Substance Abuse Treatment (CSAT) at SAMSHA has been invited to present What Pharmacists Should Know About Newer Synthetic Drugs of Abuse. In this Tuesday, April 23 keynote address, Dr. Clark will discuss the pharmacological aspects of newer synthetic drugs of abuse, the clinical effects and medical management of exposure to these drugs, and the role that pharmacists can play in synthetic drug use prevention and awareness efforts with emphasis on effective/ineffective strategies in counseling youths.

The final keynote address on Wednesday, April 24 will be delivered by Atul Butte, MD, PhD, Division Chief and Associate Professor, Stanford University School of Medicine and Director, Center for Pediatric Bioinformatics, Lucile Packard Children's Hospital.

In his keynote address entitled Transforming 300 Billion Points of Data into Diagnostics, Therapeutics, and New Insights into Disease, Dr. Butte will discuss the need to translate genome-era discoveries into clinical utility now that the United States NIH budget doubling and Human Genome Project are complete. In this session, Dr. Butte will discuss the difficulties in making bench-to-bedside translations and how the nascent field of translational bioinformatics may help. Dr. Butte's lab at Stanford builds and applies tools that convert more than 300 billion points of molecular, clinical, and epidemiological data – measured by researchers and clinicians over the past decade – into diagnostics, therapeutics, and new insights into disease. Dr. Butte, a bioinformatician and pediatric endocrinologist, will highlight his lab's work on using publicly-available molecular measurements to find new uses for drugs and evaluating patients presenting with whole genomes sequenced.

Mark your calendars for April 21-24 and lay the groundwork for your attendance at the 2013 Annual Meeting. Be watching and future editions of the Mental Health Clinician as we reveal more about our exciting line-up for the 16th Annual Meeting.

Ripped from today's headlines:

“U.S. Surgeon General Regina Benjamin and the Action Alliance for Suicide Prevention, a public-private partnership, have launched a new National Strategy for Suicide Prevention, seeking to reduce deaths from suicide in the decade ahead.”

“Suicide has surpassed car accidents as the No. 1 cause of injury-related death in the United States, according to new research.”

The 2013 CPNP Annual Meeting Pre-Meeting Workshop is focused on one of the most challenging issues of our day—Suicide. On Sunday, April 21, we will kick off the Annual Meeting with a half-day workshop focused on developing state of the art skills necessary to tackle some of the most difficult and critical tasks regarding the assessment of suicide risk.

In this training, Dr. Shawn Shea describes an innovative interviewing strategy for eliciting suicidal ideation, behaviors, and intent–the Chronological Assessment of Suicide Events (the CASE Approach). The first segment of the workshop is devoted to understanding seven practical validity techniques, which form the cornerstones for effectively eliciting suicidal ideation: normalization, shame attenuation, the behavioral incident, gentle assumption, denial of the specific, the catch-all question, and symptom amplification. Dr. Shea demonstrates how these interviewing techniques can also provide powerful gateways for uncovering the types of sensitive and taboo topics that may lead to suicidal thoughts including: physical abuse, drug abuse, antisocial behavior, and incest.

The second segment of the workshop is devoted to a demonstration of how these validity techniques can be woven into a specific strategy for specifically uncovering suicidal ideation, behaviors, and intent – the Chronological Assessment of Suicide Events (the CASE Approach). The highly acclaimed CASE Approach has been described by David Jobes Ph.D., a former President of the American Association of Suicidology, as follows: “The CASE Approach moves the clinician almost imperceptibly into the secret internal workings of the mind and soul of the patient tormented by suicidal ideation. I believe that the CASE Approach is a remarkable conceptual and clinical contribution to the field of suicidology. It should be taught to any front-line clinician. It has the power to meaningfully save lives.” All interviewing techniques will be clearly demonstrated through active learning and the use of videotape examples from actual patient interviews.

Plan now to join us on Sunday morning, April 21 for a 3.5 hour ACPE accredited program on The Delicate Art of Uncovering Suicidal Ideation and Intent: The Chronological Assessment of Suicide Events (CASE Approach).

The Speaker

Shawn Christopher Shea, M.D. is an internationally acclaimed workshop leader and educational innovator in the fields of suicide prevention, resiliency, clinical interviewing, and improving medication adherence having given over 850 presentations worldwide. He has been a recipient of an Outstanding Course Award presented by the American Psychiatric Association for his presentations at their annual meetings. He is a frequent presenter at the annual meeting of the American Association of Suicidology and at the Cape Cod Symposium where his course has received the highest evaluation of the thirty courses featured over the summer. He has also presented at the Santa Fe Symposium, the Door County Summer Institute, and the Muskoka Summer Seminar Series from McMaster University.

Dr. Shea is the author of six books and numerous articles including one of the classic texts in the field of suicide prevention, The Practical Art of Suicide Assessment. His works have been translated into a variety of languages as diverse as French, Greek, Japanese, and Chinese. Both editions of his book, Psychiatric Interviewing: the Art of Understanding, have been chosen by the Medical Library Association for the Brandon/Hill List as one of the 16 most important books in the field of psychiatry.

His book on creating resiliency in difficult times - Happiness Is. - was chosen as a Brodart Library Gem, a Bowker's title to Watch, and as the Philosophy Book of the Month by the Radical Academy. Former Surgeon General C, Everett Koop, M.D., Sc.D. provided the foreword to Dr. Shea's latest book, Improving Medication Adherence: How to Talk with Patients About Their Medications which, in 2009, was chosen for Doody's Core Titles list of the most important books in the fields of medicine and nursing.

Dr. Shea is the Director of the Training Institute for Suicide Assessment and Clinical Interviewing (, a training and consultation service providing workshops, consultations, and quality assurance design in mental health assessments. Dr. Shea is also in private practice.

CPNP is pleased to make several announcements regarding the Review Course utilized extensively as a resource and as a BCPP preparatory and recertification product.

A name change will be instituted for the 2014 product. Previously the BCPP Examination Review and Recertification Course, the course will now be known as the Psychiatric Pharmacotherapy Review Course. “This name change reflects the varied uses of this product” says Review Course Editorial Board Chair Eric Kutscher, PharmD, BCPP. “Quality, comprehensive psychopharmacology education products are needed and utilized by a variety of healthcare professionals” says Kutscher. “This name change reflects our success and our continued efforts to establish this product as the psychopharmacology go-to resource for psychiatric pharmacists as well as other professionals on the healthcare team.”

The Review Course Editorial Board has been discussing and planning changes in the product development process and content throughout this year and has just recently contracted with 2014 authors as the 15 month product development process gets underway. Authors for 2014 include:

Editors for the 2014–2015 product are as follows:

  • Daniel Dugan, PharmD, BCPP

  • Megan Ehret, PharmD, BCPP, MS

  • Judith Hyatt, PharmD, BCPP, FASCP

  • Cynthia Kirkwood, PharmD, BCPP

  • Eric Kutscher, PharmD, BCPP

  • Monica Mathys, PharmD, BCPP

  • Carol Ott, PharmD, BCPP

  • Shannon Saldana, PharmD, MS, BCPP

  • Mark Watanabe, PharmD, BCPP, PhD

  • Jennifer Zacher, PharmD, BCPP


  • Leigh Anne Nelson, RPh, PharmD, BCPP, has been promoted to Associate Professor at University of Missouri-Kansas City.